Study of DS-3939a for Advanced Solid Tumors
Part of Cancer clinical trials.
This trial is testing a new drug called DS-3939a for people with advanced solid tumors that have not responded to other treatments. The study has two parts to find the right dose and see how well it works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must sign a consent form.
- Your heart function must be normal (ejection fraction of 50% or more).
- Your organs must be working well enough.
- Your tumors must be measurable on scans.
- You must be able to take care of yourself (ECOG score 0 or 1).
- You must have a tumor sample (either a fresh biopsy or an old one from the last 6 months).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new combination treatment for people with advanced solid tumors that have HER2 changes. The goal is to see if it can shrink tumors or slow growth.
This study tests a new drug (DS5361b) for people with advanced solid tumors that have high genetic instability (TMB-H or MSI-H). It aims to see if the drug can shrink tumors or slow their growth.
This trial tests a new drug, DS1025a, for people with advanced solid tumors that have stopped responding to standard treatments. The goal is to see if it is safe and how well it works.
This trial tests a new drug, D3L-002, for people with advanced solid tumors that have stopped responding to at least one prior treatment or have no standard options. The goal is to see if it can help shrink or control the cancer.
This trial tests a new drug, BSI-082, alone or with another drug (T-DXd), for people with advanced solid tumors that no longer respond to standard therapy. It aims to find the best dose and check how well it works.
This trial tests a new experimental drug called DS-3939a for people with advanced non-small cell lung cancer. It aims to see if the drug can shrink or control the cancer and how safe it is.
Hear when a new Advanced Solid Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.